Literature DB >> 35301451

Uric acid, xanthine oxidase, and vascular damage: potential of xanthine oxidoreductase inhibitors to prevent cardiovascular diseases.

Hiromitsu Sekizuka1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35301451     DOI： 10.1038/s41440-022-00891-7

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  9 in total

1.  As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.

Authors:  A-K Tausche; M Christoph; M Forkmann; U Richter; S Kopprasch; C Bielitz; M Aringer; C Wunderlich
Journal:  Rheumatol Int       Date:  2013-09-12       Impact factor: 2.631

Review 2.  Physiological Diagnostic Criteria for Vascular Failure.

Authors:  Atsushi Tanaka; Hirofumi Tomiyama; Tatsuya Maruhashi; Yasushi Matsuzawa; Toru Miyoshi; Tomoyuki Kabutoya; Kazuomi Kario; Seigo Sugiyama; Masanori Munakata; Hiroshi Ito; Shinichiro Ueda; Charalambos Vlachopoulos; Yukihito Higashi; Teruo Inoue; Koichi Node
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

3.  Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction.

Authors:  Min-A Yu; Laura G Sánchez-Lozada; Richard J Johnson; Duk-Hee Kang
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

Review 4.  New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.

Authors:  Masato Furuhashi
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-09-07       Impact factor: 4.310

Review 5.  Physiological functions and pathogenic potential of uric acid: A review.

Authors:  Rashika El Ridi; Hatem Tallima
Journal:  J Adv Res       Date:  2017-03-14       Impact factor: 10.479

6.  Prevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in Japan.

Authors:  Masanari Kuwabara; Koichiro Niwa; Akira Ohtahara; Toshihiro Hamada; Satoshi Miyazaki; Einosuke Mizuta; Kazuhide Ogino; Ichiro Hisatome
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Plasma Xanthine Oxidoreductase Activity Is Associated with a High Risk of Cardiovascular Disease in a General Japanese Population.

Authors:  Yuka Kotozaki; Mamoru Satoh; Kozo Tanno; Hideki Ohmomo; Ryo Otomo; Fumitaka Tanaka; Takahito Nasu; Satoru Taguchi; Hiroto Kikuchi; Takamasa Kobayashi; Atsushi Shimizu; Kiyomi Sakata; Jiro Hitomi; Kenji Sobue; Makoto Sasaki
Journal:  Int J Environ Res Public Health       Date:  2021-02-16       Impact factor: 3.390

Review 8.  Xanthine oxidoreductase: A leading actor in cardiovascular disease drama.

Authors:  Letizia Polito; Massimo Bortolotti; Maria Giulia Battelli; Andrea Bolognesi
Journal:  Redox Biol       Date:  2021-11-24       Impact factor: 11.799

9.  Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study.

Authors:  Sumito Sunagawa; Takashi Shirakura; Noboru Hokama; Chisayo Kozuka; Masato Yonamine; Toyotaka Namba; Satoko Morishima; Sawako Nakachi; Yukiko Nishi; Tomomi Ikema; Shiki Okamoto; Chieko Matsui; Naoki Hase; Mizuho Tamura; Michio Shimabukuro; Hiroaki Masuzaki
Journal:  J Diabetes Investig       Date:  2018-07-07       Impact factor: 4.232
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.